The Impact of Choice of NNRTI on Short-Term Treatment Outcomes among HIV-Infected Patients Prescribed Tenofovir and Lamivudine in Johannesburg, South Africa

• Kate Shearer ,

  * E-mail: kshearer@heroza.org

  Affiliation Health Economics and Epidemiology Research Office, Department of Internal Medicine, School of Clinical Medicine, Faculty of Health Sciences, University of the Witwatersrand, Johannesburg, South Africa

  ⨯
• Matthew P. Fox,

  Affiliations Health Economics and Epidemiology Research Office, Department of Internal Medicine, School of Clinical Medicine, Faculty of Health Sciences, University of the Witwatersrand, Johannesburg, South Africa, Center for Global Health & Development, Boston University, Boston, Massachusetts, United States of America, Department of Epidemiology, Boston University School of Public Health, Boston University, Boston, Massachusetts, United States of America

  ⨯
• Mhairi Maskew,

  Affiliation Health Economics and Epidemiology Research Office, Department of Internal Medicine, School of Clinical Medicine, Faculty of Health Sciences, University of the Witwatersrand, Johannesburg, South Africa

  ⨯
• Rebecca Berhanu,

  Affiliation Right to Care, Johannesburg, South Africa

  ⨯
• Lawrence Long,

  Affiliation Health Economics and Epidemiology Research Office, Department of Internal Medicine, School of Clinical Medicine, Faculty of Health Sciences, University of the Witwatersrand, Johannesburg, South Africa

  ⨯
• Ian Sanne

  Affiliations Health Economics and Epidemiology Research Office, Department of Internal Medicine, School of Clinical Medicine, Faculty of Health Sciences, University of the Witwatersrand, Johannesburg, South Africa, Right to Care, Johannesburg, South Africa, Clinical HIV Research Unit, Department of Internal Medicine, School of Clinical Medicine, Faculty of Health Sciences, University of the Witwatersrand, Johannesburg. South Africa

  ⨯